Clinical Trial Update: A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating safety and blood concentration after a single dose of Monlunabant. The study enrolled healthy-weight Japanese and Caucasian men …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Monlunabant

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED